Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
367 Leser
Artikel bewerten:
(1)

PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products

SHANGHAI, Aug. 24, 2020 /PRNewswire/ -- PharmaSources.com, the vertical B2B portal for the pharmaceutical industry, announces the launch of the virtual session CPhI China Top API Exporters & Products on 24-28 August 2020, as part of the CPhI & P-MEC China E-Trade Season (August to October 2020).

The active pharmaceutical ingredients (API) industry in China plays a pivotal role in the global pharmaceutical ecosystem. In 2019, the Chinese API manufacturers produced and exported to the world 10.12 million tons of products, valued at $33.7 billion. With the outbreak of COVID-19, the API market has experienced some uncertainties in the beginning of 2020, yet still shows its vitality in the exporting business. In the first quarter of 2020, the total export volume of APIs of China increased by 16.68%, reaching 3.90 million tons.

"The hard time is not without opportunities, as the rising demand in health and medical global wide calls for more API supplies with higher quality," commented Zing Zhou, Senior Director of PharmaSources and CPhI China. "This event is business-intensive. It will further propel the API export Business for the Chinese players in the second half of the year."

CPhI China Top API Exporters & Products will bring together the 100 cream-of-the-crop API exporters of China and showcase the most popular exporting products, seeking to break the physical limitations, facilitate direct sourcing channels and build-up connections between global buyers and key pharma player in China.

Participation is complimentary for buyers from all over the globe. Users will be able to precisely locate quality suppliers, make direct inquiries and acquire key insights into the Chinese healthcare market, by making full use of the four functions of the event:

Top Exporters Recognition

A total of 100 API companies will be recognized as Top API Exporters. They are ranked by yearly export value and enlisted by categories of vitamins, hormones, antipyretics and analgesics, antibiotics, CNS drugs, biochemicals and more.

Hot Products Gallery

The specially picked 20 products for each category will be highlighted in the Hot Products Gallery. Situated in the middle part of the webpage, this session provides intense exposure for suppliers' key products. Buyers can easily send inquiries by a simple one-click on the desired product.

Video Meetings

The video meeting function is to provide users with 1-on-1 e-meeting services. This service is totally free of charge for both the suppliers and buyers. Through the professional e-meeting platform and tailored services, they will be able to meet with their existing or potential partners from anywhere of the world.

Industry Report

The latest industry annual review will be presented for free downloads. Published by China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE), this industry whitepaper depicts the landscape of China's pharma industry against the backdrop of world economic slowdown, industry reconstruction and uncertainties. It provides statistics and insights into internationalization, legislation, and outlook of the future pharma and healthcare sectors.

For more information of the event, please visit https://www.pharmasources.com/zt/top-api

About PharmaSources

Rolled out in 2010 as an online trade platform serving the pharmaceutical industry, EN-CPhI.CN has been re-named and rebranded to PharmaSources after 10 years driving industry development. PharmaSources connects international pharma buyers and suppliers, promoting trade and development across the industry. The B2B platform features over 8,500 suppliers and 3,600,000 products in 30 major categories spanning the entire pharma supply chain and delivers services to over 90,000 active members across 211 countries and regions. To learn more about PharmaSources please go to www.pharmasources.com or email yingqi.shi@imsinoexpo.com

Contact:

Yingqi Shi
+86-2133392421
yingqi.shi@imsinoexpo.com

© 2020 PR Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.